Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Amyloid-β25-35 induces apolipoprotein D Synthesis and growth arrest in HT22 hippocampal cells.

Martínez E, Navarro A, Ordóñez C, Del Valle E, Tolivia J.

J Alzheimers Dis. 2012;30(2):233-44. doi: 10.3233/JAD-2012-112102.

PMID:
22398376
2.

Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.

Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI.

Neurobiol Dis. 2005 Nov;20(2):574-82.

PMID:
15916898
3.

Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels.

Bhatia S, Jenner AM, Li H, Ruberu K, Spiro AS, Shepherd CE, Kril JJ, Kain N, Don A, Garner B.

J Alzheimers Dis. 2013;35(3):475-86. doi: 10.3233/JAD-122278.

PMID:
23455990
4.

Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells.

Sun L, Guo C, Liu D, Zhao Y, Zhang Y, Song Z, Han H, Chen D, Zhao Y.

Neuroscience. 2011 Jun 16;184:151-63. doi: 10.1016/j.neuroscience.2011.03.059. Epub 2011 Apr 7.

PMID:
21496477
5.

Regulation of IL-1β-induced cyclooxygenase-2 expression by interactions of Aβ peptide, apolipoprotein E and nitric oxide in human neuroglioma.

Samy AS, Igwe OJ.

J Mol Neurosci. 2012 Jul;47(3):533-45. doi: 10.1007/s12031-011-9670-8. Epub 2011 Nov 19.

PMID:
22101739
6.

Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice.

Li H, Ruberu K, Muñoz SS, Jenner AM, Spiro A, Zhao H, Rassart E, Sanchez D, Ganfornina MD, Karl T, Garner B.

Neurobiol Aging. 2015 May;36(5):1820-33. doi: 10.1016/j.neurobiolaging.2015.02.010. Epub 2015 Feb 19.

PMID:
25784209
7.

Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells.

Ill-Raga G, Ramos-Fernández E, Guix FX, Tajes M, Bosch-Morató M, Palomer E, Godoy J, Belmar S, Cerpa W, Simpkins JW, Inestrosa And NC, Muñoz FJ.

J Alzheimers Dis. 2010;22(2):641-52. doi: 10.3233/JAD-2010-100474.

PMID:
20858976
9.

Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion.

Terrisse L, Séguin D, Bertrand P, Poirier J, Milne R, Rassart E.

Brain Res Mol Brain Res. 1999 Jun 18;70(1):26-35.

PMID:
10381540
10.
11.

Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease.

Bhatia S, Knoch B, Wong J, Kim WS, Else PL, Oakley AJ, Garner B.

Biochem J. 2012 Mar 15;442(3):713-21. doi: 10.1042/BJ20111166.

PMID:
22150111
12.

Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.

Allaman I, Gavillet M, Bélanger M, Laroche T, Viertl D, Lashuel HA, Magistretti PJ.

J Neurosci. 2010 Mar 3;30(9):3326-38. doi: 10.1523/JNEUROSCI.5098-09.2010.

13.

System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.

Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M.

J Neurosci. 2006 Mar 22;26(12):3345-56.

14.

Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems.

Bajo-Grañeras R, Ganfornina MD, Martín-Tejedor E, Sanchez D.

Glia. 2011 Oct;59(10):1551-66. doi: 10.1002/glia.21200. Epub 2011 Jun 17.

PMID:
21688324
15.

Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.

Santos DB, Peres KC, Ribeiro RP, Colle D, dos Santos AA, Moreira EL, Souza DO, Figueiredo CP, Farina M.

Exp Neurol. 2012 Feb;233(2):767-75. doi: 10.1016/j.expneurol.2011.11.036. Epub 2011 Dec 8.

16.
18.

Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic injury.

He X, Jittiwat J, Kim JH, Jenner AM, Farooqui AA, Patel SC, Ong WY.

Neurosci Lett. 2009 May 22;455(3):183-6. doi: 10.1016/j.neulet.2009.03.038. Epub 2009 Mar 16.

PMID:
19429117
19.

In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42)

Yatin SM, Varadarajan S, Link CD, Butterfield DA.

Neurobiol Aging. 1999 May-Jun;20(3):325-30; discussion 339-42.

PMID:
10588580

Supplemental Content

Support Center